BIIB logo

Biogen Inc. (BIIB) Free cash flow

annual FCF:

$2.52B+$1.28B(+103.57%)
December 31, 2024

Summary

  • As of today (August 23, 2025), BIIB annual free cash flow is $2.52 billion, with the most recent change of +$1.28 billion (+103.57%) on December 31, 2024.
  • During the last 3 years, BIIB annual FCF has fallen by -$829.30 million (-24.79%).
  • BIIB annual FCF is now -60.75% below its all-time high of $6.41 billion, reached on December 31, 2019.

Performance

BIIB Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

quarterly FCF:

$134.30M-$77.90M(-36.71%)
June 30, 2025

Summary

  • As of today (August 23, 2025), BIIB quarterly free cash flow is $134.30 million, with the most recent change of -$77.90 million (-36.71%) on June 30, 2025.
  • Over the past year, BIIB quarterly FCF has dropped by -$448.90 million (-76.97%).
  • BIIB quarterly FCF is now -92.71% below its all-time high of $1.84 billion, reached on June 30, 2020.

Performance

BIIB quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM FCF:

$1.85B-$448.90M(-19.55%)
June 30, 2025

Summary

  • As of today (August 23, 2025), BIIB TTM free cash flow is $1.85 billion, with the most recent change of -$448.90 million (-19.55%) on June 30, 2025.
  • Over the past year, BIIB TTM FCF has increased by +$379.10 million (+25.83%).
  • BIIB TTM FCF is now -71.19% below its all-time high of $6.41 billion, reached on December 31, 2019.

Performance

BIIB TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

BIIB Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+103.6%-77.0%+25.8%
3 y3 years-24.8%-80.8%-20.2%
5 y5 years-60.8%-92.7%-70.9%

BIIB Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.8%+120.5%-83.3%+151.2%-26.6%+80.0%
5 y5-year-60.8%+120.5%-92.7%+128.7%-70.9%+80.0%
alltimeall time-60.8%+316.1%-92.7%+116.2%-71.2%+2351.1%

BIIB Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$134.30M(-36.7%)
$1.85B(-19.6%)
Mar 2025
-
$212.20M(-69.5%)
$2.30B(-8.7%)
Dec 2024
$2.52B(+103.6%)
$694.60M(-13.8%)
$2.52B(+42.3%)
Sep 2024
-
$805.60M(+38.1%)
$1.77B(+20.5%)
Jun 2024
-
$583.20M(+34.9%)
$1.47B(+14.3%)
Mar 2024
-
$432.30M(-920.3%)
$1.28B(+3.9%)
Dec 2023
$1.24B(+8.3%)
-$52.70M(-110.4%)
$1.24B(+20.4%)
Sep 2023
-
$504.80M(+26.2%)
$1.03B(-8.6%)
Jun 2023
-
$400.00M(+4.2%)
$1.12B(-21.0%)
Mar 2023
-
$383.70M(-246.2%)
$1.42B(+24.5%)
Dec 2022
$1.14B(-65.9%)
-$262.40M(-143.6%)
$1.14B(-47.5%)
Sep 2022
-
$601.90M(-13.7%)
$2.17B(-6.1%)
Jun 2022
-
$697.70M(+571.5%)
$2.31B(-16.5%)
Mar 2022
-
$103.90M(-86.5%)
$2.77B(-17.1%)
Dec 2021
$3.35B(-9.1%)
$769.80M(+3.6%)
$3.35B(+58.7%)
Sep 2021
-
$743.40M(-35.7%)
$2.11B(-14.4%)
Jun 2021
-
$1.16B(+70.8%)
$2.46B(-21.9%)
Mar 2021
-
$676.40M(-244.5%)
$3.15B(-14.4%)
Dec 2020
$3.68B(-42.6%)
-$468.10M(-142.7%)
$3.68B(-37.0%)
Sep 2020
-
$1.10B(-40.5%)
$5.84B(-8.0%)
Jun 2020
-
$1.84B(+52.9%)
$6.35B(+1.1%)
Mar 2020
-
$1.21B(-28.9%)
$6.28B(-2.0%)
Dec 2019
$6.41B(+20.9%)
$1.69B(+5.6%)
$6.41B(+0.4%)
Sep 2019
-
$1.60B(-9.7%)
$6.38B(+0.9%)
Jun 2019
-
$1.78B(+33.4%)
$6.32B(+17.5%)
Mar 2019
-
$1.33B(-20.2%)
$5.38B(+1.5%)
Dec 2018
$5.30B(+104.8%)
$1.67B(+8.0%)
$5.30B(+6.6%)
Sep 2018
-
$1.55B(+85.2%)
$4.97B(+4.1%)
Jun 2018
-
$834.50M(-33.4%)
$4.78B(-0.2%)
Mar 2018
-
$1.25B(-6.7%)
$4.79B(+76.9%)
Dec 2017
$2.59B(-31.8%)
$1.34B(-0.5%)
$2.71B(-1.8%)
Sep 2017
-
$1.35B(+59.4%)
$2.76B(+23.9%)
Jun 2017
-
$846.40M(-202.0%)
$2.23B(-0.6%)
Mar 2017
-
-$830.00M(-159.6%)
$2.24B(-43.0%)
Dec 2016
$3.79B(+23.5%)
$1.39B(+70.7%)
$3.93B(+15.9%)
Sep 2016
-
$816.30M(-5.0%)
$3.39B(+4.6%)
Jun 2016
-
$859.00M(-0.2%)
$3.24B(-1.8%)
Mar 2016
-
$860.30M(+0.7%)
$3.30B(+7.3%)
Dec 2015
$3.07B(+15.8%)
$854.28M(+28.2%)
$3.07B(+0.9%)
Sep 2015
-
$666.25M(-27.4%)
$3.04B(-5.7%)
Jun 2015
-
$917.36M(+44.4%)
$3.23B(-0.3%)
Mar 2015
-
$635.21M(-23.1%)
$3.24B(+22.0%)
Dec 2014
$2.65B(-328.1%)
$825.97M(-3.0%)
$2.65B(+1.4%)
Sep 2014
-
$851.49M(-8.1%)
$2.62B(+11.0%)
Jun 2014
-
$926.59M(+1741.4%)
$2.36B(+17.7%)
Mar 2014
-
$50.32M(-93.6%)
$2.00B(-4.5%)
Dec 2013
-$1.16B(-171.9%)
$790.35M(+33.6%)
$2.10B(+20.1%)
Sep 2013
-
$591.73M(+3.6%)
$1.75B(+6.6%)
Jun 2013
-
$571.06M(+292.1%)
$1.64B(+0.5%)
Mar 2013
-
$145.65M(-66.8%)
$1.63B(+0.3%)
Dec 2012
$1.62B(+9.7%)
$438.87M(-9.3%)
$1.63B(+2.2%)
Sep 2012
-
$483.72M(-14.0%)
$1.59B(-0.4%)
Jun 2012
-
$562.68M(+301.7%)
$1.60B(+13.6%)
Mar 2012
-
$140.07M(-65.3%)
$1.41B(-4.8%)
Dec 2011
$1.48B(+1.6%)
$403.53M(-17.6%)
$1.48B(+1.5%)
Sep 2011
-
$489.53M(+31.6%)
$1.45B(+7.4%)
Jun 2011
-
$372.04M(+76.8%)
$1.35B(-0.7%)
Mar 2011
-
$210.47M(-44.9%)
$1.36B(-6.1%)
Dec 2010
$1.45B(+59.6%)
$382.22M(-1.8%)
$1.45B(+12.0%)
Sep 2010
-
$389.28M(+2.1%)
$1.30B(+14.5%)
Jun 2010
-
$381.43M(+27.7%)
$1.13B(+19.9%)
Mar 2010
-
$298.69M(+31.8%)
$944.23M(+3.8%)
Dec 2009
$909.25M(-29.4%)
$226.66M(+0.7%)
$909.25M(-12.4%)
Sep 2009
-
$225.02M(+16.1%)
$1.04B(-17.6%)
Jun 2009
-
$193.87M(-26.5%)
$1.26B(-0.9%)
Mar 2009
-
$263.71M(-25.8%)
$1.27B(-1.3%)
Dec 2008
$1.29B(+74.9%)
$355.30M(-20.6%)
$1.29B(+10.1%)
Sep 2008
-
$447.32M(+118.2%)
$1.17B(+33.7%)
Jun 2008
-
$204.96M(-27.0%)
$875.34M(+10.4%)
Mar 2008
-
$280.95M(+18.3%)
$792.56M(+7.6%)
Dec 2007
$736.53M
$237.51M(+56.3%)
$736.53M(+8.9%)
DateAnnualQuarterlyTTM
Sep 2007
-
$151.92M(+24.4%)
$676.36M(-7.4%)
Jun 2007
-
$122.17M(-45.7%)
$730.15M(-6.1%)
Mar 2007
-
$224.93M(+26.8%)
$777.26M(+20.9%)
Dec 2006
$642.96M(+12.6%)
$177.33M(-13.8%)
$642.96M(+0.8%)
Sep 2006
-
$205.72M(+21.5%)
$637.94M(+16.9%)
Jun 2006
-
$169.28M(+86.8%)
$545.58M(+6.0%)
Mar 2006
-
$90.62M(-47.4%)
$514.71M(-9.9%)
Dec 2005
$571.13M(+59.4%)
$172.31M(+52.0%)
$571.13M(+25.1%)
Sep 2005
-
$113.36M(-18.1%)
$456.37M(+4.0%)
Jun 2005
-
$138.41M(-5.9%)
$438.67M(+14.9%)
Mar 2005
-
$147.04M(+155.5%)
$381.74M(+4.0%)
Dec 2004
$358.22M(-536.7%)
$57.55M(-39.8%)
$366.97M(+64.3%)
Sep 2004
-
$95.67M(+17.4%)
$223.29M(+71.3%)
Jun 2004
-
$81.47M(-38.4%)
$130.35M(+691.5%)
Mar 2004
-
$132.28M(-253.6%)
$16.47M(-120.1%)
Dec 2003
-$82.03M(-716.0%)
-$86.13M(-3263.1%)
-$82.03M(-1537.4%)
Sep 2003
-
$2.72M(-108.4%)
$5.71M(-27.4%)
Jun 2003
-
-$32.40M(-195.9%)
$7.86M(-83.1%)
Mar 2003
-
$33.77M(+1995.2%)
$46.56M(+249.6%)
Dec 2002
$13.32M(-84.6%)
$1.61M(-67.0%)
$13.32M(-70.3%)
Sep 2002
-
$4.88M(-22.5%)
$44.78M(+12.7%)
Jun 2002
-
$6.29M(+1085.3%)
$39.75M(-33.0%)
Mar 2002
-
$531.00K(-98.4%)
$59.29M(-31.4%)
Dec 2001
$86.43M(+182.9%)
$33.08M(<-9900.0%)
$86.43M(+23.2%)
Sep 2001
-
-$150.00K(-100.6%)
$70.17M(+0.9%)
Jun 2001
-
$25.84M(-6.6%)
$69.52M(+43.1%)
Mar 2001
-
$27.67M(+64.5%)
$48.60M(+59.1%)
Dec 2000
$30.55M(-36.6%)
$16.82M(-2199.5%)
$30.55M(+15.2%)
Sep 2000
-
-$801.00K(-116.3%)
$26.53M(-33.7%)
Jun 2000
-
$4.91M(-49.0%)
$40.01M(-21.1%)
Mar 2000
-
$9.63M(-24.8%)
$50.73M(+5.2%)
Dec 1999
$48.21M(+1333.6%)
$12.79M(+0.9%)
$48.21M(+14.1%)
Sep 1999
-
$12.69M(-18.8%)
$42.27M(+66.2%)
Jun 1999
-
$15.62M(+119.7%)
$25.43M(+48.8%)
Mar 1999
-
$7.11M(+3.8%)
$17.09M(+408.1%)
Dec 1998
$3.36M(-139.0%)
$6.85M(-264.8%)
$3.36M(-133.9%)
Sep 1998
-
-$4.16M(-157.1%)
-$9.91M(-126.7%)
Jun 1998
-
$7.28M(-210.1%)
$37.05M(-36.3%)
Mar 1998
-
-$6.61M(+3.1%)
$58.17M(-6.3%)
Dec 1997
-$8.63M(-17.3%)
-$6.42M(-115.0%)
$62.08M(-41.2%)
Sep 1997
-
$42.80M(+50.7%)
$105.60M(+81.4%)
Jun 1997
-
$28.40M(-1151.9%)
$58.20M(+2958.5%)
Mar 1997
-
-$2.70M(-107.3%)
$1.90M(-110.0%)
Dec 1996
-$10.44M(+167.5%)
$37.10M(-906.6%)
-$19.10M(-69.6%)
Sep 1996
-
-$4.60M(-83.5%)
-$62.76M(-6.1%)
Jun 1996
-
-$27.90M(+17.7%)
-$66.86M(+20.8%)
Mar 1996
-
-$23.70M(+261.3%)
-$55.36M(+35.5%)
Dec 1995
-$3.90M(-81.2%)
-$6.56M(-24.6%)
-$40.86M(-30.7%)
Sep 1995
-
-$8.70M(-47.0%)
-$58.98M(+14.6%)
Jun 1995
-
-$16.40M(+78.3%)
-$51.48M(+14.2%)
Mar 1995
-
-$9.20M(-62.7%)
-$45.08M(+413.3%)
Dec 1994
-$20.76M(-6.7%)
-$24.68M(+1957.0%)
-$8.78M(-143.9%)
Sep 1994
-
-$1.20M(-88.0%)
$20.00M(-26.7%)
Jun 1994
-
-$10.00M(-136.9%)
$27.30M(-43.9%)
Mar 1994
-
$27.10M(+561.0%)
$48.70M(+32.3%)
Dec 1993
-$22.24M(+160.2%)
$4.10M(-32.8%)
$36.80M(-37.9%)
Sep 1993
-
$6.10M(-46.5%)
$59.30M(-5.0%)
Jun 1993
-
$11.40M(-25.0%)
$62.40M(+33.3%)
Mar 1993
-
$15.20M(-42.9%)
$46.80M(+38.9%)
Dec 1992
-$8.55M(+33.0%)
$26.60M(+189.1%)
$33.70M(+258.5%)
Sep 1992
-
$9.20M(-319.0%)
$9.40M(-491.7%)
Jun 1992
-
-$4.20M(-300.0%)
-$2.40M(-1300.0%)
Mar 1992
-
$2.10M(-8.7%)
$200.00K(-108.0%)
Dec 1991
-$6.43M(+1507.2%)
$2.30M(-188.5%)
-$2.50M(-30.6%)
Sep 1991
-
-$2.60M(+62.5%)
-$3.60M(+28.6%)
Jun 1991
-
-$1.60M(+166.7%)
-$2.80M(-212.0%)
Mar 1991
-
-$600.00K(-150.0%)
$2.50M(-725.0%)
Dec 1990
-$400.00K(-96.2%)
$1.20M(-166.7%)
-$400.00K(-75.0%)
Sep 1990
-
-$1.80M(-148.6%)
-$1.60M(-900.0%)
Jun 1990
-
$3.70M(-205.7%)
$200.00K(-105.7%)
Mar 1990
-
-$3.50M
-$3.50M
Dec 1989
-$10.60M
-
-

FAQ

  • What is Biogen Inc. annual free cash flow?
  • What is the all time high annual FCF for Biogen Inc.?
  • What is Biogen Inc. annual FCF year-on-year change?
  • What is Biogen Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Biogen Inc.?
  • What is Biogen Inc. quarterly FCF year-on-year change?
  • What is Biogen Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Biogen Inc.?
  • What is Biogen Inc. TTM FCF year-on-year change?

What is Biogen Inc. annual free cash flow?

The current annual FCF of BIIB is $2.52B

What is the all time high annual FCF for Biogen Inc.?

Biogen Inc. all-time high annual free cash flow is $6.41B

What is Biogen Inc. annual FCF year-on-year change?

Over the past year, BIIB annual free cash flow has changed by +$1.28B (+103.57%)

What is Biogen Inc. quarterly free cash flow?

The current quarterly FCF of BIIB is $134.30M

What is the all time high quarterly FCF for Biogen Inc.?

Biogen Inc. all-time high quarterly free cash flow is $1.84B

What is Biogen Inc. quarterly FCF year-on-year change?

Over the past year, BIIB quarterly free cash flow has changed by -$448.90M (-76.97%)

What is Biogen Inc. TTM free cash flow?

The current TTM FCF of BIIB is $1.85B

What is the all time high TTM FCF for Biogen Inc.?

Biogen Inc. all-time high TTM free cash flow is $6.41B

What is Biogen Inc. TTM FCF year-on-year change?

Over the past year, BIIB TTM free cash flow has changed by +$379.10M (+25.83%)
On this page